165 related articles for article (PubMed ID: 26958783)
21. Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
Martino M; Bonizzoni E; Moscato T; Recchia AG; Fedele R; Gallo GA; Console G; Messina G; Morabito F
Biol Blood Marrow Transplant; 2015 May; 21(5):881-8. PubMed ID: 25636377
[TBL] [Abstract][Full Text] [Related]
22. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
[TBL] [Abstract][Full Text] [Related]
23. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
[TBL] [Abstract][Full Text] [Related]
24. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
Bertani G; Santoleri L; Martino M; Fedele R; Moscato T; Marenco P; Grillo G; Zucchetti E; Lotesoriere I; Lando G; Cesana C; Cairoli R; Rossini S
Transfusion; 2014 Aug; 54(8):2028-33. PubMed ID: 24588265
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.
Panch SR; Yau YY; Fitzhugh CD; Hsieh MM; Tisdale JF; Leitman SF
Transfusion; 2016 May; 56(5):1058-65. PubMed ID: 27167356
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
27. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
Basara N; Schmetzer B; Blau IW; Bischoff M; Günzelmann S; Kirsten D; Fauser AA
Bone Marrow Transplant; 2000 Feb; 25(4):371-6. PubMed ID: 10723579
[TBL] [Abstract][Full Text] [Related]
28. Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Motlló C; Sancho JM; Grífols JR; Juncà J; Morgades M; Ester A; Rodríguez I; Vives S; Batlle M; Guardia R; Ferrà C; Gallardo D; Millá F; Feliu E; Ribera JM
Cytotherapy; 2014 Mar; 16(3):406-11. PubMed ID: 24176544
[TBL] [Abstract][Full Text] [Related]
29. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests.
Li Y; Chang Y; Xu L; Zhang X; Huang X
Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236
[TBL] [Abstract][Full Text] [Related]
30. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
Arat M; Arslan O; Ayyildiz E; Topcuoglu P; Dalva K; Ilhan O
Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells.
van Os R; van Schie ML; Willemze R; Fibbe WE
J Hematother Stem Cell Res; 2002 Jun; 11(3):513-21. PubMed ID: 12183836
[TBL] [Abstract][Full Text] [Related]
33. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
De la Rubia J; Arbona C; Del Cañizo C; Arrieta R; De Arriba F; Pascual MJ; Sanjuan I; Díaz MA; Brunet S; Alegre A; Insunza A; Espigado I; Zamora C; De la Serna J; Serrano D; Bargay J; Petit J; Martínez D; Verdeguer A; Ribera JM; Martínez C; Benlloch L; Sanz MA
J Hematother Stem Cell Res; 2002 Aug; 11(4):705-9. PubMed ID: 12201959
[TBL] [Abstract][Full Text] [Related]
34. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
[TBL] [Abstract][Full Text] [Related]
35. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting PBSC mobilization and collection in healthy donors.
Lysák D; Koza V; Jindra P
Transfus Apher Sci; 2005 Nov; 33(3):275-83. PubMed ID: 16209935
[TBL] [Abstract][Full Text] [Related]
37. Smoking is an important factor that affects peripheral blood progenitor cells yield in healthy male donors.
Zhen C; Fang X; Ding M; Wang X; Yuan D; Sui X; Liu X; Zhang L; Xu H; Li Y; Wang X
J Clin Apher; 2020 Jan; 35(1):33-40. PubMed ID: 31693224
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
Anderlini P; Donato M; Lauppe MJ; Huh YO; Martin TG; Chan KW; Champlin RE; Körbling M
Br J Haematol; 2000 Jun; 109(4):770-2. PubMed ID: 10929027
[TBL] [Abstract][Full Text] [Related]
39. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
[TBL] [Abstract][Full Text] [Related]
40. [In vivo effect of rhG-CSF on the CXCR-4 expression of hematopoietic progenitor or stem cells in bone marrow and peripheral blood].
Zhao XY; Chang YJ; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):857-60. PubMed ID: 16277858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
